|
|
|
|
Impax Laboratories Confirms Patent Challenge Relating to WELCHOL(R) 625 mg Tablets
- (NewsRx.com) Impax Laboratories, Inc.(NASDAQ:IPXL) confirms that it has initiated a challenge of patents listed by Daiichi Sankyo, Inc. in connection with its WELCHOL (Colesevelam HCl) tablets, 625 mg (see also Impax Laboratories, Inc.). Impax...
|
|
|
Welchol Patent Infringement Suit Filed Against Impax Labs
Welchol Patent Infringement Suit Filed Against Impax Labs.
|
|
|
Daiichi Sankyo and Genzyme suing Impax over Welchol copy
Daiichi Sankyo and partner Genzyme Corp are suing Impax Laboratories over the latters plans to sell a generic version of their cholesterol drug Welchol in the USA.Impax has filed an Abbreviated New Drug Application on Welchol (colesevelam) and...
|
|
|
Impax challenges Genzyme, partner on Welchol
Impax Laboratories challenges Genzyme, Daiichi Sankyo patents on cholesterol drug Buzz up!Companies: HAYWARD, Calif! (AP) -- Impax Laboratories said Friday that it is the target of a lawsuit over its plans to produce a generic version of the cholesterol...
|
|
|
Impax Labs sued by Daiichi Sankyo and Genzyme after challenging Welchol patent in USA
Keywords: Impax, Generics, Welcol, Patent challenge, Daiichi Sankyo, Genzyme Related Articles 6 January 2010 24 December 2009 16 December 2009 18 November 2009 Recent Articles 18 January 2010 18 January 2010 18 January 2010 Related Discussion There are no...
|
|
|
Medical News: Impax Laboratories Confirms Patent Challenge Relating To WELCHOL(R) 625 Mg Tablets
Impax Laboratories, Inc.(NASDAQ:IPXL) confirms that it has initiated a challenge of patents listed by Daiichi Sankyo, Inc. in connection with its WELCHOL (Colesevelam HCl) tablets, 625 mg. Impax filed its Abbreviated New Drug Application ("ANDA")...
|
|
|
Impax Laboratories Confirms Patent Challenge Relating To WELCHOL(R) 625 Mg Tablets
Impax Laboratories, Inc.(NASDAQ:IPXL) confirms that it has initiated a challenge of patents listed by Daiichi Sankyo, Inc. in connection with its WELCHOL (Colesevelam HCl) tablets, 625 mg. Impax filed its Abbreviated New Drug Application ("ANDA")...
|
|
|
BiomedReports: News and FDA Updates for GenVec (Nasdaq:GNVC), Geron (Nasdaq:GERN), Impax (NASDAQ:IPXL)
BioMedReports.Com, the news portal which covers Wall Street's biomedical sector and delivers financial and investment intelligence to a community of highly informed investors has Healthcare stock news and updates to its calendar database of Clinical Trials...
|
|
|
To Your Good Health: Rheumatic fever not cause of blockage
Q: I am a 48-year-old woman.I had rheumatic fever when I was 9 and a mild heart murmur for less than a year. I have been on prophylactic penicillin daily since that time. Despite eating well, having normal cholesterol and no family history of heart...
|
|
|
BiomedReports: News and FDA Updates for GenVec (Nasdaq:GNVC), Ger...
Companies: GenVec, Inc.(GNVC), Geron Corp. (GERN), Impax Laboratories, Inc. (IPXL) BioMedReports.Com, the news portal which covers Wall Street's biomedical sector and delivers financial and investment intelligence to a community of highly informed...
|
|
|
Rheumatic fever not cause of blockage
Q: I am a 48-year-old woman.I had rheumatic fever when I was 9 and a mild heart murmur for less than a year. I have been on prophylactic penicillin daily since that time. Despite eating well, having normal cholesterol and no family history of heart...
|
|
|
::: Impax Laboratories Confirms Patent Challenge Relating to WELCHOL 625 mg Tablets
HAYWARD, Calif.--(BUSINESS WIRE)--Impax Laboratories, Inc.(NASDAQ:IPXL) today confirms that it has initiated a challenge of patents listed by Daiichi Sankyo, Inc. in connection with its WELCHOL (Colesevelam HCl) tablets, 625 mg. Impax filed its...
|
|
|
News and FDA Updates for GenVec (Nasdaq:GNVC), Geron (Nasdaq:GERN), Impax (NASDAQ:IPXL)
BioMedReports.Com, the news portal which covers Wall Street's biomedical sector and delivers financial and investment intelligence to a community of highly informed investors has Healthcare stock news and updates to its calendar database of Clinical Trials...
|
|
|
Genzyme, Daiichi Try To Halt Impaxs Generic Welchol
Genzyme Corp.and Daiichi Sankyo Inc. have dragged Impax Laboratories to court in an effort to block it from marketing a generic version of their cholesterol drug Welchol. Genzyme, Daiichi Try To Halt Impaxs Generic Welchol.
|
|
|
Genzyme & Daiichi Move To Halt Impaxs Generic Welchol
Genzyme Corp.and Daiichi Sankyo Inc. have dragged Impax Laboratories to court in an effort to block it from marketing a generic version of their cholesterol drug Welchol. Genzyme & Daiichi Move To Halt Impaxs Generic Welchol.
|
|
|
Bay Bizz Buzz: Wells Fargo and other bank shares plummet
Groups accusing San Ramon-based Chevron Corp.of contaminating a huge swath of rainforest in Ecuador are asking a U.S. court to block the oil company from taking the dispute to international arbitration. The groups filed a lawsuit Thursday in U.S.
|
|
|
Impax challenges cholesterol drug patents
Impax Laboratories Inc.is challenging patents listed by Daiichi Sankyo Inc. for the cholesterol-lowering drug Welchol. Hayward-based Impax (NASDAQ: IPXL) wants to make a generic version of 625-milligram tablets of colesevelam hydrochloride, which...
|
|
|
Groups try to block Chevron's Ecuador legal move
Groups accusing San Ramon-based Chevron Corp.of contaminating a huge swath of rainforest in Ecuador are asking a U.S. court to block the oil company from taking the dispute to international arbitration. The groups filed a lawsuit Thursday in U.S.
|
|
|
Groups try to block Chevron's Ecuador legal move
Groups accusing San Ramon-based Chevron Corp.of contaminating a huge swath of rainforest in Ecuador are asking a U.S. court to block the oil company from taking the dispute to international arbitration. The groups filed a lawsuit Thursday in U.S.
|
|
|
News and FDA Updates for GenVec (Nasdaq:GNVC), Geron (Nasdaq:GERN), Impax (NASDAQ:IPXL)
BioMedReports.Com, the news portal which covers Wall Street's biomedical sector and delivers financial and investment intelligence to a community of highly informed investors has Healthcare stock news and updates to its calendar database of Clinical Trials...
|
|
|
News and FDA Updates for GenVec (Nasdaq:GNVC), Geron (Nasdaq:GERN), Impax (NASDAQ:IPXL)
BioMedReports.Com, the news portal which covers Wall Street's biomedical sector and delivers financial and investment intelligence to a community of highly informed investors has Healthcare stock news and updates to its calendar database of Clinical Trials...
|
|
|
Daiichi, Genzyme Sue Impax for Welchol Patent Infringement
ePublishing :: CMS, Hosting & Web Development | Copyright by FDAnews All right Daiichi, Genzyme Sue Impax for Welchol Patent Infringement.
|
|
|
Impax Challenges Genzyme, Partner on Welchol
ePublishing :: CMS, Hosting & Web Development | Copyright by FDAnews All right Impax Challenges Genzyme, Partner on Welchol.
|
|
|
Impax Laboratories Confirms Patent Challenge Relating to WELCHOL 625 mg Tablets
Impax Laboratories Confirms Patent Challenge Relating to WELCHOL 625 mg Tablets HAYWARD, Calif.--(BUSINESS WIRE)--Impax Laboratories, Inc.(NASDAQ:IPXL - News) today confirms that it has initiated a challenge of patents listed by Daiichi Sankyo, Inc.
|
|
|
Impax Laboratories Confirms Patent Challenge Relating to WELCHOL 625 mg Tablets
HAYWARD, Calif.-- (BUSINESS WIRE) -- Impax Laboratories, Inc.(NASDAQ:IPXL) today confirms that it has initiated a challenge of patents listed by in connection with its WELCHOL (Colesevelam HCl) tablets, 625 mg. Impax filed its Abbreviated New Drug...
|
